Most multiple sclerosis relapses resolve within about three to four months, though recovery can stretch up to a year. The median time to relapse recovery is 111 days, based on clinical data from the CombiRx trial. But “how long symptoms last” depends heavily on whether you’re experiencing a true relapse, a temporary flare-up, or the gradual worsening that comes with progressive forms of the disease. These are very different timelines.
What Counts as a Relapse
A true MS relapse is a new or worsening neurological symptom that lasts at least 24 hours and isn’t triggered by fever, infection, or heat. That 24-hour minimum is part of the formal McDonald Criteria used for diagnosis. In practice, the symptoms of a genuine relapse persist for days to weeks before they begin improving, and the full recovery phase extends much longer than the acute flare itself.
The 2024 revisions to the McDonald Criteria now allow for a broader diagnostic approach, recognizing that some neurological symptoms may not fit the classic “attack” pattern but still reflect active MS. This matters because not every episode of worsening is a relapse, and distinguishing between types of symptom flares changes both the expected timeline and the treatment approach.
Typical Relapse Recovery Timeline
An analysis of 240 relapse recovery events found that 80% of people who recovered did so within the first six months. By one year, 94% had recovered. The median recovery time was 111 days, roughly four months. Recovery isn’t linear. Most improvement happens in the earlier weeks, then gradually slows.
Specific symptoms follow their own patterns. Vision loss from optic neuritis, one of the most common relapse symptoms, typically begins improving within two weeks. Many people see complete recovery by four to six weeks, though continued improvement can occur for up to a year. Sensory symptoms like numbness, tingling, or the tight banding sensation sometimes called the “MS hug” tend to resolve over weeks to months, depending on the severity of the underlying inflammation.
Not Every Relapse Resolves Completely
One of the harder realities of MS is that relapses don’t always leave you back at baseline. Across multiple studies, somewhere between 34% and 59% of relapses result in incomplete recovery, meaning some degree of neurological deficit persists after six months or more. In one large cohort, 44.6% of early relapses left a residual deficit.
Disease-modifying therapies appear to improve the odds somewhat. In one dataset, 71.5% of relapses in people on these treatments resolved completely, compared to 63.8% in people not on treatment. That difference didn’t reach statistical significance in that particular study, but the trend is consistent with what neurologists observe clinically. Each relapse carries some risk of permanent change, which is a key reason early and consistent treatment matters.
Pseudo-Relapses: Symptoms That Last Hours, Not Weeks
If your symptoms flare up and then resolve within hours or a day or two, you’re likely experiencing a pseudo-relapse rather than a true one. These episodes look and feel like a relapse, often revisiting symptoms from a previous attack, but they’re triggered by something external rather than new inflammation in the brain or spinal cord.
The most common triggers are infections (especially urinary tract or upper respiratory infections), physical or emotional stress, and increased body temperature. The heat-related version is called Uhthoff’s phenomenon: a hot shower, exercise, or a warm day temporarily worsens existing neurological symptoms. The key feature of a pseudo-relapse is that symptoms appear and resolve in sync with the trigger. Cool down, clear the infection, or reduce the stressor, and the symptoms fade. No new damage is occurring.
This distinction matters because pseudo-relapses don’t require the same treatment as true relapses, and they don’t signal disease progression. But telling them apart in the moment can be difficult, so tracking your triggers and symptom patterns helps you and your neurologist make the right call.
Progressive MS: Symptoms That Don’t Come and Go
In progressive forms of MS, the question shifts from “how long does this episode last” to “how quickly are things changing.” Primary progressive MS (PPMS) and secondary progressive MS (SPMS) involve a slow, steady accumulation of disability rather than distinct relapses followed by recovery periods. People with SPMS experience far fewer acute relapses, with an annualized relapse rate of just 0.01 compared to 0.08 for relapsing-remitting MS in recent real-world data from UK clinics.
The symptoms in progressive MS are, by definition, persistent. Walking difficulty, fatigue, bladder problems, or cognitive changes may worsen gradually over months and years without the dramatic peaks and valleys of relapsing-remitting disease. This doesn’t mean the rate of change is the same for everyone. Some people progress slowly over decades, while others experience faster decline.
Gradual Worsening Without Relapses
Research over the past several years has identified a pattern called progression independent of relapse activity, sometimes described as “smoldering” MS. A large proportion of people with MS experience clinical worsening even when they’re relapse-free and their MRI scans show no new inflammatory lesions. This slow, diffuse process appears to be present from the earliest stages of the disease, not just in later progressive phases.
This is significant because it means some symptom worsening isn’t tied to discrete episodes at all. It’s a gradual, ongoing process driven by widespread low-level damage throughout the nervous system. For people tracking their symptoms and wondering why things feel slightly worse despite no obvious relapse, this underlying process may be part of the explanation. It also helps explain why relapses alone are poor predictors of long-term disability. Two people can have similar relapse histories but very different outcomes depending on how much smoldering activity is happening beneath the surface.
What Affects How Long Your Symptoms Last
Several factors influence recovery time from a relapse. The severity of the initial attack matters: mild sensory symptoms tend to resolve faster than episodes involving significant weakness or coordination problems. Your age plays a role, with younger people generally recovering more quickly and more completely. How much cumulative damage your nervous system has already sustained also affects its ability to bounce back, since the brain’s capacity to reroute around damaged areas diminishes over time.
High-dose corticosteroids, typically given intravenously over three to five days, are the standard treatment for acute relapses. They speed up recovery but don’t appear to change the final outcome. In optic neuritis studies, vision recovered faster with intravenous treatment than without it, with the biggest differences showing up at days 4 and 15 after treatment. The practical takeaway: steroids can shorten the worst part of a relapse by days to weeks, but the overall recovery arc still plays out over months.
For people in relapsing-remitting MS, the frequency of relapses has been declining in recent years as disease-modifying therapies have become more effective and are started earlier. This means fewer episodes to recover from in the first place, which over time translates to less accumulated disability.